Northwest Biothrputcs Inc
(NWBO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,727 | -20,946 | -35,794 | -30,144 | -42,722 |
| Depreciation Amortization | 671 | 298 | 7,642 | 6,626 | 5,564 |
| Accounts payable and accrued liabilities | N/A | -65 | N/A | 4,493 | N/A |
| Other Working Capital | -5,410 | -2,491 | 1,678 | 8,030 | 3,050 |
| Other Operating Activity | 6,037 | 13,453 | -8,112 | -9,413 | 17,753 |
| Operating Cash Flow | $-19,429 | $-9,751 | $-34,586 | $-20,408 | $-16,355 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -225 | N/A | 45,595 | N/A | N/A |
| Other Investing Activity | 0 | -164 | -193 | 0 | 0 |
| Investing Cash Flow | $-225 | $-164 | $45,402 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,500 | 4,000 | 15,195 | 11,196 | 9,131 |
| Debt Repayment | -4,331 | -749 | -12,931 | -2,982 | -2,982 |
| Common Stock Issued | 2,219 | 688 | 3,736 | 3,357 | 3,257 |
| Other Financing Activity | -420 | 0 | 1,871 | 7,121 | 7,221 |
| Financing Cash Flow | $3,968 | $3,939 | $7,871 | $18,692 | $16,627 |
| Exchange Rate Effect | 138 | 40 | 3,420 | 1,847 | 1,208 |
| Beginning Cash Position | 22,224 | 22,224 | 117 | 117 | 117 |
| End Cash Position | 6,676 | 16,288 | 22,224 | 248 | 1,597 |
| Net Cash Flow | $-15,548 | $-5,936 | $22,107 | $131 | $1,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,429 | -9,751 | -34,586 | -20,408 | -16,355 |
| Capital Expenditure | -225 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -19,654 | -9,751 | -34,586 | -20,408 | -16,355 |